JIA patients without CD N = 321 | JIA patients with CD N = 8 | P-value§ | |
---|---|---|---|
Sex (female), n (%) | 240 (74.8) | 6 (75) | 0.45 |
Age at JIA diagnosis, yrs, median (IQR) | 4 (2.2–7.9) | 4.4 (3.6–6.1) | 0.32‡ |
JIA Subtype, n (%) | |||
Oligoarticular | 213 (66.4) | 2 (25) | 0.02* |
Polyarticular | 55 (17.1) | 2 (25) | 0.63 |
Systemic | 28 (8.7) | 1 (12.5) | 0.53 |
Undifferentiated | 12 (3.7) | 3 (37.5) | 0.004* |
Follow-up duration, yrs, median (IQR) | 5 (2.7–8.8) | 9.4 (3.6–12.4) | 0.13‡ |
Uveitis, n (%) | 46 (14.3) | 2 (25) | 0.33 |
Family history of autoimmunity, n (%) | 147 (45.8) | 7 (87.5) | 0.03* |
ANA positivity, n (%) | 125 (38.9) | 3 (37.5) | 1 |
DMARD therapy, n (%) | |||
cDMARDs | 233 (72.6) | 7 (87.5) | 0.7 |
bDMARDs | 127 (39.6) | 7 (87.5) | 0.009* |
cDMARDs + bDMARDs | 117 (36.4) | 7 (87.5) | 0.005* |